Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CLRB

Cellectar Biosciences (CLRB)

Cellectar Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLRB
DateTimeSourceHeadlineSymbolCompany
01/14/20255:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
01/12/20255:00PMGlobeNewswire Inc.Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare ConferenceNASDAQ:CLRBCellectar Biosciences Inc
12/11/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
12/10/20244:00PMGlobeNewswire Inc.Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate RestructuringNASDAQ:CLRBCellectar Biosciences Inc
11/18/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
11/18/20246:05AMGlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
11/18/20245:46AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLRBCellectar Biosciences Inc
11/15/20243:33PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
11/14/20243:53PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
11/14/20243:47PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
11/14/20247:05AMGlobeNewswire Inc.Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225NASDAQ:CLRBCellectar Biosciences Inc
11/13/20243:45PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CLRBCellectar Biosciences Inc
11/13/20243:45PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CLRBCellectar Biosciences Inc
11/12/20247:05AMGlobeNewswire Inc.Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of CancerNASDAQ:CLRBCellectar Biosciences Inc
11/11/20243:05PMGlobeNewswire Inc.Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024NASDAQ:CLRBCellectar Biosciences Inc
11/07/20245:40AMGlobeNewswire Inc.Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024NASDAQ:CLRBCellectar Biosciences Inc
11/01/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
11/01/20244:00PMGlobeNewswire Inc.Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-QNASDAQ:CLRBCellectar Biosciences Inc
10/29/20244:09PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLRBCellectar Biosciences Inc
10/29/20244:03PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
10/29/20243:56PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
08/26/20245:40AMGlobeNewswire Inc.Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s MacroglobulinemiaNASDAQ:CLRBCellectar Biosciences Inc
08/23/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
08/23/20244:00PMGlobeNewswire Inc.Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from NasdaqNASDAQ:CLRBCellectar Biosciences Inc
08/14/20246:15PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
08/14/20244:00PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CLRBCellectar Biosciences Inc
08/13/20245:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
08/13/20245:40AMGlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
08/09/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
08/08/20244:15PMGlobeNewswire Inc.UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024NASDAQ:CLRBCellectar Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CLRB